Louisiana Drug Utilization Review
The Louisiana Medicaid Pharmacy Benefits Management program uses several different drug utilization review (DUR) applications. The retrospective drug utilization review program in Louisiana is called LaDUR. The program, through a contract with the fiscal intermediary, Unisys, administers LaDUR as a component of its Drug Utilization Review (DUR) system. Rather than concentrate solely on the patient's prescription utilization, LaDUR focuses on the patient’s disease states.
Drug Utilization Review Board
The Louisiana Department of Health and Hospitals established a Drug Utilization Review Board to assist the agency in assessing its Drug Utilization Review Program.
DUR Board Functions:
LaDUR Board Membership
Federal statute specifies the general board membership. The membership of the DUR Board shall consist of at least one-third but not more that 51% licensed and actively practicing physicians and at least one-third licensed and actively practicing pharmacists. The committee shall be composed of at least eight members (or approved designees) appointed by the secretary of the Department of Health and Hospitals.
The committee shall consist of health care professionals who have recognized knowledge in: